Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced enzymatic synthesis patent analysis for high-purity Clopidogrel intermediates. Delivers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104263797A details a high-yield enzymatic resolution process for R-1-aminotetralin, offering significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1302116C reveals a novel enzymatic route for high-purity cyclopentene intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel catalytic route for posaconazole intermediate ensuring high purity and cost efficiency for pharmaceutical supply chains globally. This report analyzes patent CN115448911B for strategic sourcing.
Patent CN100558905C details a lipase-based resolution for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101045936B details a novel enzymatic resolution process using succinic anhydride, offering significant cost reduction and simplified purification for pharmaceutical intermediates.
Novel route from Itaconic Anhydride using chiral hydrogenation and lipase hydrolysis for high-purity Sacubitril intermediates. Cost-effective and scalable manufacturing solution.
Advanced synthesis of DL-neopentyl glycine via glycylglycine acetylation. High-purity amino acid intermediate for pharma. Cost-effective scalable production.
Novel biocatalytic route for l-menthol using Bacillus subtilis ECU0554. High substrate tolerance up to 500mM and >96% ee. Ideal for flavor and pharma intermediates.
Patent CN100404686C details enzymatic resolution of C-24 hydroxy vitamin D isomers, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel enzymatic method for L-2-aminobutyric acid production. Low cost, high yield, scalable process for pharmaceutical intermediates and supply chain optimization.
Advanced enzymatic resolution synthesis for chiral antifungal intermediates. Cost-effective, scalable production of high-purity pharmaceutical ingredients with superior stereocontrol.
Patent CN101538542B reveals a novel Pseudomonas esterase for high-purity mandelic acid. This biocatalytic route offers significant cost reduction and supply chain reliability for chiral intermediates.
Patent CN101134943B reveals a novel Alcaligenes strain for >99.9% e.e. mandelic acid. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN112442474B reveals a robust Fusarium oxysporum lactamase for optically pure (-) gamma-lactam production, offering superior stability and cost-effective manufacturing solutions.
Patent CN116376872A reveals high-efficiency esterase mutants for (S)-3-cyclohexene-1-carboxylic acid, offering cost reduction and scalable biocatalysis for anticoagulant manufacturing.
Patent CN105392891B enables high-yield production of optically active D/L amino acids with thiol groups. Enhances supply chain reliability and reduces manufacturing costs for peptide synthesis.
Patent CN100432060C details advanced synthesis of levofloxacin intermediates. Enhance supply chain reliability and reduce manufacturing costs with optimized chiral resolution.
Novel enzymatic resolution process ensures greater than 99 percent ee value. Cost-effective Raney nickel catalyst reduces manufacturing expenses for reliable supply chain partners.
Patent CN1317481A details a scalable synthetic route for 4,5-diamino shikimic acid derivatives from isophthalic acid, offering significant cost reduction and supply stability for neuraminidase inhibitor manufacturing.